SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-18-000147
Filing Date
2018-01-11
Accepted
2018-01-11 20:39:57
Documents
1
Period of Report
2018-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1821018.html 3  
1 OWNERSHIP DOCUMENT zk1821018.xml 3 15464
  Complete submission text file 0001178913-18-000147.txt   16989
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Issuer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLZMAN STREET, WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address
Hadar Ilan (Reporting) CIK: 0001727727 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36621 | Film No.: 18524567